WuXi Biologics (Cayman) Inc. (HKG:2269)
Hong Kong · Delayed Price · Currency is HKD 32.00
+0.50 (1.59%)
Jul 28, 2025, 4:09 PM HKT
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of 128.18 billion as of July 25, 2025. Its market cap has increased by 173.23% in one year.
Market Cap
128.18B
Enterprise Value
125.93B
Revenue
19.87B
Ranking
n/a
PE Ratio
37.72
Stock Price
32.00
Market Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 32.04B to 128.18B, an increase of 300.07%. That is a compound annual growth rate of 18.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 128.18B | 77.78% |
| Dec 31, 2024 | 72.10B | -42.32% |
| Dec 29, 2023 | 124.99B | -50.53% |
| Dec 30, 2022 | 252.68B | -35.37% |
| Dec 31, 2021 | 390.94B | -6.90% |
| Dec 31, 2020 | 419.91B | 228.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 276.12B |
| Hansoh Pharmaceutical Group Company | 203.94B |
| JD Health International | 154.09B |
| Innovent Biologics | 152.40B |
| Akeso | 137.87B |
| Sino Biopharmaceutical | 121.08B |
| CSPC Pharmaceutical Group | 98.67B |
| Sichuan Kelun-Biotech Biopharmaceutical | 84.65B |